The full content of Annals is available to subscribers

Subscribe/Learn More  >
Brief Reports |

Diltiazem and Akathisia

Ann Intern Med. 1983;99(6):794-795. doi:10.7326/0003-4819-99-6-794
Text Size: A A A
This excerpt has been provided in the absence of an abstract.

Calcium entry blockers or calcium antagonists are being used for a growing number of cardiovascular problems (1). Because diltiazem (Cardizem; Marion Laboratories, Kansas City, Missouri), a recent addition to this group, offers certain advantages over the other currently available calcium antagonists (nifedipine and verapamil), it can be expected to be prescribed with increasing frequency (2). We report a previously unreported adverse effect of diltiazem, akathisia.

A 62-year-old man with several medical problems was admitted to the Stanford Medical Service on 13 January 1983. For the previous 15 years he had had poorly controlled hypertension, adult onset (type II) diabetes mellitus,



diltiazem ; akathisia

First Page Preview

View Large
First page PDF preview





Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Buy Now for $42.00

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Related Articles
Topic Collections
PubMed Articles
Diltiazem and akathisia. Ann Intern Med 1983;99(6):794-5.
Calcium channel blockers: spectrum of side effects and drug interactions. Acta Pharmacol Toxicol (Copenh) 1986;58 Suppl 2():119-30.
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.